Management of Shortness of Breath in Patients on Clozapine

Initial Assessment

• Assess vital signs including oxygen saturation, respiratory rate, heart rate, and blood pressure to determine the severity of dyspnea and potential hemodynamic compromise, as recommended by the National Comprehensive Cancer Network 1
• Evaluate for signs of respiratory distress such as labored breathing, use of accessory muscles, and inability to speak in full sentences, following guidelines from the National Comprehensive Cancer Network 1
• Review medication history, focusing on clozapine duration, dosage, and any recent changes, according to the American Heart Association 2
• Examine for peripheral edema, jugular venous distention, and pulmonary rales which may indicate fluid retention or heart failure, as suggested by the American Heart Association 2

Diagnostic Workup

• Obtain an ECG to evaluate for myocarditis, ischemia, or other cardiac abnormalities, as recommended by the American Heart Association 2
• Consider echocardiography to assess cardiac function, particularly if there are signs of heart failure, following guidelines from the American Heart Association 2

Management Approach

• Administer supplemental oxygen for hypoxemia to maintain oxygen saturation above 94%, as recommended by the National Comprehensive Cancer Network 1
• Position the patient upright to optimize respiratory mechanics, following guidelines from the National Comprehensive Cancer Network 1
• If signs of severe respiratory distress or impending respiratory failure are present, prepare for potential airway management, as suggested by the American Heart Association 3
• Consider diuretic therapy to reduce fluid overload in patients with heart failure, according to the American Heart Association 2
• Evaluate the need for temporary reduction or discontinuation of clozapine in consultation with psychiatry for patients with heart failure, as recommended by the American Heart Association 2
• Monitor fluid status closely with daily weights and intake/output measurements in patients with heart failure, following guidelines from the American Heart Association 2
• Initiate appropriate antimicrobial therapy based on likely pathogens for patients with respiratory infection, as recommended by the National Comprehensive Cancer Network 1
• Consider adjunctive therapies such as bronchodilators if bronchospasm is present in patients with respiratory infection, following guidelines from the National Comprehensive Cancer Network 1
• Consider opioids in low doses (e.g., morphine 2.5-10 mg PO q2h prn) for refractory dyspnea if no contraindications exist, as suggested by the National Comprehensive Cancer Network 1, 4
• For anxiety associated with dyspnea, benzodiazepines may be used cautiously (e.g., lorazepam 0.5-1 mg PO q4h prn), as recommended by the National Comprehensive Cancer Network 1
• Non-pharmacologic interventions such as fans directed at the face can help reduce the sensation of dyspnea, following guidelines from the National Comprehensive Cancer Network 4

Monitoring and Follow-up

• Monitor respiratory status, vital signs, and oxygen saturation frequently during acute management, as recommended by the National Comprehensive Cancer Network 1
• Schedule follow-up echocardiography to assess response to treatment in patients with heart failure, following guidelines from the American Heart Association 2